
STAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE OFFICER
Veteran Oncology Researcher to Guide Investment in Breakthrough Cancer Treatments LOS ANGELES, July 10, 2023 /CryptoMediaWire/ — Stand Up To Cancer® (SU2C) today announced that Julian Adams, Ph.D., a longtime oncology researcher and retired pharmaceutical industry chief executive, was named the organization’s first Chief Science Officer. In this newly created position, Dr. Adams will lead the development of strategic…